Current status of breast cancer in Nepal

Mohan Giri, Anju Puri, Bibhuti Upreti


Breast carcinoma is one of the most common and dreaded diseases of women, and in Nepal, it is second most common cancer. The situation is more alarming in the rural areas where the majority of women are illiterate and ignorant about the hazards of breast cancer. Different screening strategies such as rural cancer registries and camp approach for cancer detection have been found useful in minimizing the problem of breast cancer in the villages. Advanced presentation of breast cancer and the problem of late diagnosis is well documented in Nepal. Moreover, diagnostic workup, treatment and palliative services are inadequate in most parts of Nepal. A better understanding current situation of breast cancer can help government to formulate breast cancer prevention strategy in Nepal. In this review, authors present an overview of the burden of breast cancer, risk factors, screening, and cancer care among Nepalese women.


Breast cancer, Nepal, Risk factors, Screening, Treatment

Full Text:



American Cancer Society. Cancer facts & figures, 2019. Available at: Accessed on 8 April, 2019.

Parada Jr H, Sun X, Tse CK, Olshan AF, Troester MA. Lifestyle patterns and survival following breast cancer carolina breast cancer study. Epidemiol. 2019;30(1):83-92.

Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J National Cancer Inst. 2011;103(2):117-28.

Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Can Bio Med. 2014;11(2):101.

Singh YP, Sayami P. Management of breast cancer in Nepal. J Nepal Med Assoc. 2009;48(175):252-7.

Pun CB, Pradhananga KK, Siwakoti B, Subedi K, Moore MA. Malignant neoplasm burden in Nepal-Data from the seven major cancer service hospitals for 2012. Asian Pac J Cancer Prev. 2015;16(18):8659-63.

Benz CC. Impact of aging on the biology of breast cancer. Critic Rev Oncol/Hematol. 2008;66(1):65-74.

Gupta A, Shridhar K, Dhillon PK. A review of breast cancer awareness among women in India: Cancer literate or awareness deficit?. European J Canc. 2015;51(14):2058-66.

Sathian B, Nagaraja SB, Banerjee I, Sreedharan J, De A, Roy B, et al. Awareness of breast cancer warning signs and screening methods among female residents of Pokhara valley, Nepal. Asian Pac J Cancer Prev. 2014;15(11):4723-6.

Shrestha K. Breast cancer knowledge and screening practice among women visited to KIST medical college. Nepal Med Coll J. 2012;14(4):308-11.

Piya MK, Acharya SC. Oncology in Nepal. South Asian J Canc. 2012;1(1):5-8.

Globocan. Fact sheets by population, 2018. Available at: Accessed on 8 April 2019.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Canc J Clinic. 2018;68(6):394-24.

White MC, Babcock F, Hayes NS, Mariotto AB, Wong FL, Kohler BA, et al. The history and use of cancer registry data by public health cancer control programs in the United States. Canc. 2017;123:4969-76.

Pradhananga KK, Baral M, Shrestha BM. Multi-institution hospital-based cancer incidence data for Nepal: an initial report. Asian Pac J Canc Prev. 2009;10(2):259-62.

Binu VS, Chandrashekhar TS, Subba SH, Jacob S, Kakria A, Gangadharan P, et al. Cancer pattern in Western Nepal: a hospital based retrospective study. Asian Pac J Canc Prev. 2007;8:183-6.

Lee SK, Kim SW, Yu JH, Lee JE, Kim JY, Woo J, et al. Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer? Breast Canc Res Treat. 2019;173(1):189-9.

Thapa B, Singh Y, Sayami P, Shrestha UK, Sapkota R, Sayami G. Breast cancer in young women from a low risk population in Nepal. Asian Pac J Cancer Prev. 2013;14(9):5095-9.

Barnard M, Boeke C, Tamimi R. Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta Rev Cancer. 2015;1856:73-85.

Godet I, Gilkes DM. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integ Canc Sci Ther. 2017;4(1):10.

Kim H, Choi DH. Distribution of BRCA1 and BRCA2 mutations in Asian patients with breast cancer. J Breast Canc. 2013;16(4):357-65.

Bhatta B, Thapa R, Shahi S, Bhatta Y, Pandeya DR, Paudel BH. A pilot study on screening of BRCA1 mutations (185delAG, 1294del40) in Nepalese breast cancer patients. Asian Pac J Cancer Prev. 2016;17(4):1829-32.

Fan L, Goss PE, Strasser-Weippl K. Current status and future projections of breast cancer in Asia. Breast Care. 2015;10(6):372-8.

Bhattacharya S, Adhikary S. Evaluation of risk factors, diagnosis and treatment in carcinoma breast-a retrospective study. Kathmandu Univ Med J (KUMJ). 2006;4(1):54-60.

Singh Y, Sayami P, Sayami G, Nakagawa H, Koreeda T, Hatano T, et al. Nepalese breast cancer in relation to reproductive factors: comparison between Nepalese and Japanese cases. Anticancer Res. 2002;22:319-323.

Liu JY, Chen TJ, Hwang SJ. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan. Int J Environ Res Pub Health. 2016;13(5):482

Tara S, Agrawal CS, Agrawal A. Validating breast self-examination as screening modalities for breast cancer in eastern region of Nepal: a population-based study. Kathmandu Univ Med J. 2008;6:89-3.

Lertkhachonsuk AA, Yip CH, Khuhaprema T, Chen DS, Plummer M, Jee SH, et al. Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol. 2013;14:e497-e507.

Bhandari PM, Thapa K, Dhakal S, Bhochhibhoya S, Deuja R, Acharya P, et al. Breast cancer literacy among higher secondary students: results from a cross-sectional study in Western Nepal. BMC Canc. 2016;16(1):119.

Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Brit J Canc. 2013;108(11):2205.

Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol. 2013;14(7):583-9.

Bellavance EC, Kesmodel SB. Decision-making in the surgical treatment of breast cancer: factors influencing women’s choices for mastectomy and breast conserving surgery. Front Oncol. 2016;6:74.

Chen K, Liu J, Zhu L, Su F, Song E, Jacobs LK. Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: a NCDB analysis. Oncotarget. 2015;6(37):40127.

Shrestha K. Psychological impact after mastectomy among Nepalese women: a qualitative study. Nepal Med Coll J. 2012;14(2):153-6.

Lamichhane N, Pradhan M, Neupane PR, Shrestha BM, Dhakal HP, Thakur BK. Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer. Nepal Med Coll J. 2007;9(1):22-6.

Sapkota A, Shrestha S, Sedhain A, Koirala S, Kafle P. Problems of breast cancer survivors living in an urban area of Nepal. Asia-Pacific J Oncol Nurs. 2016;3(3):289.

Ojha B, Kumar R, Prabhune A. Past, present and future of breast cancer in Nepal: A review. Global J Med Public Health. 2018;7(1).

Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321(3):288-300.

Zheng R, Han S, Duan C, Chen K, You Z, Jia J, et al. Role of taxane and anthracycline combination regimens in the management of advanced breast cancer: a meta-analysis of randomized trials. Med. 2015;94(17).

Crozier JA, Swaika A, Moreno-Aspitia A. Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines. World J Clinic Oncol. 2014;5(3):529.

Vorobiof DA. Recent advances in the medical treatment of breast cancer. F1000Res. 2016;5:2786.

Karn A, Jha AK, Shrestha S, Acharya B, Poudel S, Bhandari RB. Tamoxifen for breast cancer. Surv. 2010;11:12.

Pistelli M, Della Mora A, Ballatore Z, Berardi R. Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects. Curr Oncol. 2018;25(2):e168.

Larionov AA. Current therapies for human epidermal growth factor receptor 2-positive metastatic breast cancer patients. Front Oncol. 2018;8:89.

Gyawali B. Me, too. J Global Oncol. 2016;2(3):99.

Yoon SY, Oh J. Neuropathic cancer pain: prevalence, pathophysiology, and management. Korean J Intern Med. 2018;33(6):1058-69.

Van Poznak CH, Temin S, Yee GC, Janjan NA, Barlow WE, Biermann JS, et al. American society of clinical oncology clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. J Clin Oncol. 2011;29(9):1221-7.

Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev. 2006;10(6):419-29.

Rosell L, Alexandersson N, Hagberg O, Nilbert M. Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care. BMC Health Services Res. 2018;18(1):249.

Dieterich M, Stubert J, Reimer T, Erickson N, Berling A. Influence of lifestyle factors on breast cancer risk. Breast Care. 2014;9(6):407-14.